FRAMEWORK

Serial Number 98906568
688

Registration Progress

Application Filed
Dec 17, 2024
Under Examination
May 6, 2025
Approved for Publication
Mar 11, 2025
Published for Opposition
Mar 11, 2025
Registered

Basic Information

Serial Number
98906568
Deadline
November 6, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
December 17, 2024
Published for Opposition
March 11, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
May 6, 2025
Application
Pending
Classes
042

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom
USPTO Deadlines 2 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUB Apr 10, 2025 88 days overdue Medium Until May 10, 2025
ITU SOU
Notice of Allowance Mailed - SOU Required
NOAM Nov 06, 2025 122 days High Until May 06, 2026
Next deadline: Notice of Allowance Mailed - SOU Required on November 06, 2025 (122 days)

Application History

8 events
Date Code Type Description
May 6, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 11, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 PUBO A PUBLISHED FOR OPPOSITION
Mar 5, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2025 DOCK D ASSIGNED TO EXAMINER
Dec 17, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Medical and scientific research in the field of solid tumors

Additional Information

Pseudo Mark
FRA MEWORK; FOLATE RECEPTOR ALPHA MEWORK

Classification

International Classes
042